Results 111 to 120 of about 11,815 (206)

Efficacy and safety of preservative-free versus preserved timolol eye drops in glaucoma: A randomized crossover study. [PDF]

J Chin Med Assoc
Ko YH, Fan CC, Ko YC, Kuang TM, Chang YF, Liu CJ, Chen MJ.   +6 more
europepmc   +1 more source

A retrospective study on the treatment of superficial infantile hemangiomas of the head and neck using topical compresses with 0.5% timolol maleate eye drops. [PDF]

Front Pediatr
Yang L, Chen F, Li K, Chen J, Liu W, Ji Y, Xia M, Xie J, Ding K, Zeng Q, Hou F.   +10 more
europepmc   +1 more source

Use of Bimatoprost Intracameral Implant for the Treatment of Glaucoma: A Focused Narrative Review. [PDF]

Cureus
Rizwan Khan AY.
europepmc   +1 more source

A stability-indicating RP-HPLC method for the simultaneous quantification of brimonidine tartrate and timolol maleate in bulk drug substances and pharmaceutical dosage forms. [PDF]

Sci Rep
Mestareehi A.
europepmc   +1 more source

Hypotony following the use of topical carbonic anhydrase inhibitors in glaucoma patients: a case report and review of literature. [PDF]

Int J Surg Case Rep
AlTariqi SM, Halawani MA, AlOtaiby ND.
europepmc   +1 more source

Machine learning-driven drug repurposing for HER2-positive breast cancer. [PDF]

Sci Rep
Dinesh BGH, Ganjipete S, Kumar BS, Ammunje DN, Kunjiappan S, Seetharaman PK, Ramar M, Chidambaram K, Pavadai P.   +8 more
europepmc   +1 more source

Latanoprost/timolol fixed-dose combination: two decades of efficacy and safety in glaucoma management. [PDF]

BMC Ophthalmol
Martinez-de-la-Casa J, Corsino P, Grzybowski A, Tatham A, Vignesh SO, Hassan T.   +5 more
europepmc   +1 more source

Assessment of the Effectiveness, Tolerability, and Safety of the Preservative-Free Fixed Combination of Timolol, Dorzolamide, and Brimonidine Compared to Separate Therapies in Patients with Glaucoma, a Randomized Controlled Trial. [PDF]

Clin Ophthalmol
Belalcazar S, Tornero-Jimenez A, Mejia-Morales C, Olvera-Montaño O, Muñoz-Villegas P.   +4 more
europepmc   +1 more source

Intermediate Term Results of a Novel Minimally Invasive Keratoprosthesis. [PDF]

Ophthalmol Sci
Sharma J, Dohlman TH, Zhou C, Taniguchi E, Albalakhi A, Somasunder T, York P, Lei F, Liu J, Wood RJ, Chodosh J, Pineda R, Paschalis EI.   +12 more
europepmc   +1 more source

Preclinical Evaluation of Safety and Efficacy of QLS-111: A Novel Formulation of an Adenosine Triphosphate-Sensitive Potassium Channel Opener. [PDF]

Ophthalmol Sci
Wirostko BM, Roy Chowdhury U, Brandano LA, Casale RA, DeWalt DJ, Rykard LR, Htoo TM, Fautsch MP.   +7 more
europepmc   +1 more source